[1]
“Validation of Reverse Phase High-performance Liquid Chromatography Analytical Method for Osimertinib Mesylate and its Degradation Products for Osimertinib Mesylate Tablets”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 6, pp. 739–748, Nov. 2022, doi: 10.25004/IJPSDR.2022.140611.